Basal insulin and bolus insulin
Sponsors
Mount Sinai Hospital, Canada, Rabin Medical Center
Conditions
DM2Type 2 Diabetes
Phase 3
Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
CompletedNCT02194595
Start: 2014-09-30End: 2022-02-28Updated: 2022-04-11
Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department
NCT03051243
Start: 2017-10-01End: 2019-11-01Target: 60Updated: 2017-09-11